REQUEST A DEMO
Total
USD $0.00
Search more companies

Medizen Labs Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Medizen Labs Private Limited Profile Updated: November 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Medizen Labs Private Limited is an unlisted company, incorporated on 20/12/2011. It has its registered office in the State of Karnataka, India. Company's corporate identification number (CIN) is U24232KA2011PTC061744 and registration number is 061744. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
# 28, Sunder Ind. Estate, N.T.Y.Layout, Mysore Road
Bangalore; Karnataka; Postal Code: 560026

Contact Details: Purchase the Medizen Labs Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Medizen Labs Private Limited report to view the information.
Outstanding Shares:
Purchase the Medizen Labs Private Limited report to view the information.
Registered Capital:
Purchase the Medizen Labs Private Limited report to view the information.
Incorporation Date:
December 20, 2011
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
25%
Company Performance
Financial values in the chart are available after Medizen Labs Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
38.76%
Total operating revenue
38.79%
Operating profit (EBIT)
615.54%
EBITDA
380.59%
Net Profit (Loss) for the Period
625.64%
Total assets
31.59%
Total equity
41.68%
Operating Profit Margin (ROS)
2.1%
Net Profit Margin
1.56%
Return on Equity (ROE)
23.68%
Debt to Equity Ratio
-6.24%
Quick Ratio
0.53%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?